Fundraising FoxSymBiosis — 2021 Investments
2 investments dated 2021 · listed companies and verified rows first · show all
Clene is a clinical-stage biopharmaceutical company developing nanotherapeutics that target cellular energy impairments to treat neurodegenerative diseases and restore neuronal health.
BiotechDeep TechHealthtechSalt Lake City, US
Mark Mortenson(Executive Officer)inReed N. Wilcox(Independent Director)Morgan Brown(Executive Officer)inRobert Glanzman(Executive Officer)inTae Heum Jeong(Executive Officer)Robert Etherington(President, Chief Executive Officer, and Director)
Board seatChidozie Ugwumba· per SEC Form D · $9.3M raise · filed May 2021
Biotechnology company using multiplex gene editing to develop genetically engineered porcine organs for human transplantation.
BiotechBrookline, US
Luhan Yang(President, Secretary and Treasurer)Geoff MacKay(Chief Executive Officer)
BoardGeorge M. Church(Director)
Co-investorsAlta PartnersARCH Venture PartnersCatalio Capital Management, LPHBM Healthcare InvestmentsHBM PartnersKhosla Ventures+13 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.